JPRN-UMIN000010556已完成未知
The efficacy and response of switching from either donepezil or galantamine to rivastigmine transdermal patch in Alzheimer disease: multi-modal neuroimaging analysis (structural and functional neuroimaging) of open-label, clinical trial - Multi-modal neuroimaging analysis of open-trial of switching from either donepezil or galantamine to rivastigmine
Department of Neuropsychiatry, Keio University School of Medicine,0 个研究点目标入组 41 人开始时间: 2013年4月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 41
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •either previous history or now taking other choline inhibitors (rivastigmine) and memantine, taking antipsychotic or antidepressant medication ,there was a previous history of mental illness or substance abuse,either an MRI or a CT scan had revealed focal brain lesions,routine blood tests (including evaluation of serum vitamin B12 and thyroid function) were abnormal findings , the patient has pacemaker, other findings in terms with the aims of this study
研究者
相似试验
已完成
不适用
The efficacy and response of switching from donepezil to galantamine in Alzheimer disease: multi-modal neuroimaging analysis (structural and functional neuroimaging) of open-label, clinical trialAlzheimer diseaseJPRN-UMIN000009470Department of Neuropsychiatry, Keio University School of Medicine,38
尚未招募
不适用
Efficacy and quality of life changes in switching traditional rapid acting insulin to ultra rapid Lispro in patients with type 2 diabetestype 2 diabetes mellitusJPRN-UMIN000048528Minami Osaka Hospital Internal Medicine15
已完成
不适用
Investigation of the effects of switching to a high genetic barrier protease inhibitor based regimen on low level viremia, immune activation and neurocognitive performance in patients on antiviral therapyaidsHIV1002146010047438NL-OMON44785niversitair Medisch Centrum Utrecht65
尚未招募
3 期
B/F/TAF to DTG/3TC Switch StudyHIV/AIDSPACTR202404870570433niversity of Nairobi240
进行中（未招募）
1 期
Assessing the safety and efficacy of switching to Azarga (Brinzolamide/Timolol Fixed Combination), as replacement therapy in patients with uncontrolled intraocular pressure - not applicableEUCTR2009-015795-10-SIAlcon d.o.o.120